MANGALAM DRUGS & ORGANICS LTD. - Intimation As Per Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 For Getting Grant From Medicines For Malaria Venture (MMV) For Research And Development Of Pyronaridine.

Home
Market News
My Portfolio
My Watchlist
Trends

Investment Tool
Forex
Indices
Sectors
Mutual Funds
Gainers / Losers
Import Portfolio
All Pages

Download	< Back
26 Aug 2024
Intimation for getting grant from MMV for research and development of Pyronaridine.
View all announcements for MANGALAM DRUGS & ORGANICS LTD.	Source: BSE India

ALL MONEYWIZ PAGES

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us

Stocks

Mutual Funds

Investment tracking